Overview

Bluebird Bio, Inc. is a biotechnology company dedicated to developing gene therapies for severe genetic diseases and cancer. The company focuses on addressing rare genetic conditions, offering potentially transformative treatments for patients who have few other therapeutic options.

Therapeutic areas

Genetic DiseasesOncology

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to bluebird bio, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this bluebird bio, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.